131 related articles for article (PubMed ID: 7204134)
21. MOPP, ABVD, or both to treat Hodgkin's disease.
Aisenberg AC
N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680765
[No Abstract] [Full Text] [Related]
22. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
[No Abstract] [Full Text] [Related]
23. MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
Glick JH; Tsiatis A
Ann Intern Med; 1986 Jun; 104(6):876-8. PubMed ID: 2422998
[No Abstract] [Full Text] [Related]
24. MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
Colonna P; Andrieu JM
Lancet; 1985 May; 1(8439):1224. PubMed ID: 2860433
[No Abstract] [Full Text] [Related]
25. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Canellos GP
Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
[No Abstract] [Full Text] [Related]
26. Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
Hagemeister FB; Fuller LM; Velasquez WS; Sullivan JA; North L; Butler JJ; Johnston DA; Shullenberger CC
Cancer Treat Rep; 1982 Apr; 66(4):789-98. PubMed ID: 7074649
[No Abstract] [Full Text] [Related]
27. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
Sampi K; Honda T; Hattori M
Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
[No Abstract] [Full Text] [Related]
28. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
29. The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.
Gobbi PG; Cavalli C; Rossi A; Bertoloni D; Galeone F; Pieresca C; Grignani E
Haematologica; 1987; 72(6):523-8. PubMed ID: 3126109
[No Abstract] [Full Text] [Related]
30. [Results of the treatment of patients with Hodgkin's disease by the MOPP protocol in relation to the histological type of the disease].
Krajewska B; Dziewulska-Bokiniec A; Goszczyńska-Matysiak E; Kacprzak G
Nowotwory; 1987; 37(4):317-21. PubMed ID: 3451197
[No Abstract] [Full Text] [Related]
31. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
[TBL] [Abstract][Full Text] [Related]
33. Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
Sinniah D; Lin HP
Cancer; 1979 May; 43(5):1587-9. PubMed ID: 445354
[TBL] [Abstract][Full Text] [Related]
34. Skin infiltration in Hodgkin's disease.
Gordon RA; Lookingbill DP; Abt AB
Arch Dermatol; 1980 Sep; 116(9):1038-40. PubMed ID: 7416756
[TBL] [Abstract][Full Text] [Related]
35. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
[TBL] [Abstract][Full Text] [Related]
36. The cure of disseminated Hodgkin's disease: prospects and problems.
Streuli RA; Ultmann JE
Ann Intern Med; 1980 May; 92(5):693-5. PubMed ID: 7387012
[No Abstract] [Full Text] [Related]
37. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
Specht L; Nissen NI
Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
[TBL] [Abstract][Full Text] [Related]
38. Alternating drug combinations for advanced Hodgkin's disease.
N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
[No Abstract] [Full Text] [Related]
39. Chemotherapy in the treatment of Hodgkin's disease.
Canellos GP; Come SE; Skarin AT
Semin Hematol; 1983 Jan; 20(1):1-24. PubMed ID: 6189191
[No Abstract] [Full Text] [Related]
40. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
